Physician profile
Bubu Banini
NPI 1427320985
$39,486.10
in general payments reported to CMS, 2019-2025
4 companies · $6,088 in 2025
The $6,088 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2023: $2,713 · 2024: $31K · 2025: $6,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Travel and Lodging: $2,211 · Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,203.75 |
| Travel and Lodging | $2,210.50 |
| Food and Beverage | $967.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $27,393.90 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11,891.25 | 2024-2025 | |
| Eisai INC. | $104.51 | 2019 | |
| Gilead Sciences, INC. | $96.44 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bubu Banini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.